button bars forest bayes pooled summary circles
 
DMFS

mML - NA - PDL1 positive metastatic/adv melanoma (mML) mML - (neo)adjuvant (NA) mML - NA - PDL1 positive

versus placebo
pembrolizumab alone vs. placebo 1 0.60 [0.49; 0.73], 1 RCT, I2=0% conclusive
unassessable degree of certainty

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons